Literature DB >> 14602033

Copper phosphoramidite-catalyzed enantioselective desymmetrization of meso-cyclic allylic bisdiethyl phosphates.

Umberto Piarulli1, Christelle Claverie, Philippe Daubos, Cesare Gennari, Adriaan J Minnaard, Ben L Feringa.   

Abstract

[reaction: see text] A highly regio-, diastereo-, and enantioselective desymmetrization of five-, six-, and seven-membered meso-cyclic allylic bis-diethyl phosphates (2a, 2b, and 2c, respectively) was obtained with diethylzinc, using catalytic amounts of [Cu(OTf)](2).C(6)H(6) and phosphoramidite ligands 5. Enantiomeric excesses of up to 87, 94, and >98% were obtained for the addition of diethylzinc to cyclopentene, cyclohexene, and cycloheptene bis-diethyl phosphates, respectively.

Entities:  

Year:  2003        PMID: 14602033     DOI: 10.1021/ol035807l

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Divalent and Multivalent Activation in Phosphate Triesters: A Versatile Method for the Synthesis of Advanced Polyol Synthons.

Authors:  Christopher D Thomas; James P McParland; Paul R Hanson
Journal:  European J Org Chem       Date:  2009-10-08

2.  An exceptional P-H phosphonite: biphenyl-2,2'-bisfenchylchlorophosphite and derived ligands (BIFOPs) in enantioselective copper-catalyzed 1,4-additions.

Authors:  T Kop-Weiershausen; J Lex; J-M Neudörfl; B Goldfuss
Journal:  Beilstein J Org Chem       Date:  2005-08-26       Impact factor: 2.883

3.  Desymmetrization of meso-Dibromocycloalkenes through Copper(I)-Catalyzed Asymmetric Allylic Substitution with Organolithium Reagents.

Authors:  Shermin S Goh; Sureshbabu Guduguntla; Takashi Kikuchi; Martin Lutz; Edwin Otten; Makoto Fujita; Ben L Feringa
Journal:  J Am Chem Soc       Date:  2018-05-31       Impact factor: 15.419

4.  Desymmetrization of meso-bisphosphates using copper catalysis and alkylzirconocene nucleophiles.

Authors:  Reece Jacques; Robert D C Pullin; Stephen P Fletcher
Journal:  Nat Commun       Date:  2019-01-03       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.